Skip to main content

Table 1 Characteristics of participating patients with gastroesophageal reflux disease (GERD), by country of residence

From: Impact of gastroesophageal reflux disease on work absenteeism, presenteeism and productivity in daily life: a European observational study

  Germany Greece Norway Spain Sweden UK
Number of patients 495 505 525 477 368 308
Women, n (%) 295 (59.6) 265 (52.5) 303 (57.7) 280 (58.7) 223 (60.6) 171 (55.5)
Mean age, years (SD) 58.6 (14.5) 52.5 (14.3) 57.2 (15.2) 59.8 (15.7) 56.2 (15.0) 56.4 (15.5)
Mean body mass index, kg/m 2 (SD) 27.7 (5.1) 27.4 (4.5) 26.9 (4.7) 28.0 (4.3) 27.5 (4.8) 28.0 (5.8)
Mean time since GERD diagnosis, years (SD) 3.5 (3.8) 2.3 (3.0) 6.1 (7.2) 4.5 (4.7) 6.0 (8.3) 5.7 (5.8)
Employed, n (%)* 192 (38.8) 258 (51.1) 233 (44.4) 161 (33.8) 196 (53.3) 132 (42.9)
Reason for index visit, n (%)       
   First occurrence of reflux symptoms 58 (11.7) 180 (35.6) 43 (8.2) 55 (11.7) 47 (12.8) 59 (19.2)
   Recurrent symptoms after a remission period 256 (51.7) 211 (41.8) 176 (33.5) 137 (29.1) 82 (22.3) 94 (30.5)
   Persistence of reflux symptoms 45 (9.1) 55 (10.9) 81 (15.4) 63 (13.4) 37 (10.1) 66 (21.4)
   Follow-up visit (asymptomatic patient) 112 (22.6) 28 (5.5) 174 (33.1) 201 (42.7) 108 (29.4) 85 (27.6)
   Other 30 (6.1) 15 (3.0) 51 (9.7) 15 (3.2) 94 (25.5) 8 (2.6)
Symptoms ≥2 days/week, n (%)       
   Heartburn 81 (16.4) 213 (42.2) 86 (16.4) 158 (33.1) 50 (13.6) NR
   Regurgitation 75 (15.2) 216 (42.8) 85 (16.2) 147 (30.8) 42 (11.4) NR
No symptoms during previous week, n (%)       
   Heartburn 307 (62.0) 77 (15.2) 319 (60.8) 184 (38.6) 235 (63.9) NR
   Regurgitation 346 (69.9) 91 (18.0) 343 (65.9) 202 (42.3) 245 (66.6) NR
Moderate-to-severe symptoms, n (%)       
   Heartburn 161 (32.5) 347 (68.7) 154 (29.3) 223 (46.8) 95 (25.8) NR
   Regurgitation 124 (25.1) 289 (57.2) 127 (24.2) 204 (42.8) 91 (24.7) NR
  1. NR = not recorded; SD = standard deviation.
  2. * The employed category included 9 patients for whom employment details were missing, but who were assumed to be in employment as they completed the Work Productivity and Activity Impairment Questionnaire for patients with GERD.